An agent that activates natural killer cells and is useful in renal cell carcinoma is
Ref-Katzung 10/e p816 Recombinant IL-2 is used for the treatment of maligant melanoma and renal cell carcinoma
Aldesleukin
Etanercept
Leflunomide
Thalidomide
Other topics and Adverse effects